Clostridium Notes

Clostridium Genus

• Large, heterogeneous collection of spore-forming anaerobic rods.
• Includes pathogens like C. tetani (tetanus) and C. botulinum (botulism).
• C. difficile has emerged as an infectious complication of antibiotic usage.
• Other species are recognized pathogens, like C. perfringens (myonecrosis).

Clostridium difficile

• Trigger Words: Spore former, fecal carriage, toxins A and B, antibiotic-associated diarrhea, pseudomembranous colitis.
• Biology and Virulence:
  • Large anaerobic rod with abundant spore formation.
  • Rapid growth and production of volatile fatty acids.
  • Produces two toxins:
    • Enterotoxin (toxin A): attracts neutrophils, stimulates cytokine release.
    • Cytotoxin (toxin B): increases intestinal wall permeability, causes diarrhea.
  • Spore formation allows persistence in hospital environments and resistance to decontamination.
  • Resistance to antibiotics (clindamycin, cephalosporins, fluoroquinolones) allows overgrowth in patients exposed to these antibiotics.
• Epidemiology:
  • Colonizes intestines of a small proportion of healthy individuals (<5%).
  • Antibiotic exposure leads to overgrowth and disease (endogenous infection).
• Diseases:
  • Antibiotic-associated diarrhea: develops 5-10 days after antibiotic initiation; can be brief or protracted.
  • Pseudomembranous colitis: severe form with profuse diarrhea, abdominal cramping, fever; whitish plaques (pseudomembranes) form over colonic tissue; can be fatal.
• Diagnosis:
  • Confirmed by detecting cytotoxin or enterotoxin or the toxin genes in feces.
• Treatment, Prevention, and Control:
  • Discontinue implicated antibiotic.
  • Treat with metronidazole or vancomycin in severe cases; fecal transplants can be used for recurrent disease.
  • Relapse is common (antibiotics don't kill spores); a second course of therapy is often successful.
  • Hospital rooms should be carefully cleaned.

Clostridium perfringens

• Trigger Words: Spore former, myonecrosis, sepsis, food poisoning.
• Biology and Virulence:
  • Large gram-positive rods with spores rarely observed.
  • Distinct colony morphology and rapid growth.
  • Produces toxins and enzymes that lyse blood cells and destroy tissues, leading to sepsis, hemolysis, and myonecrosis.
  • Produces heat-sensitive enterotoxin that binds to the small intestine epithelium, leading to fluid and ion loss (watery diarrhea).
• Epidemiology:
  • Ubiquitous; present in soil, water, and intestinal tracts of humans and animals.
  • Type A strains are responsible for most human infections.
• Diseases:
  • Food poisoning associated with contaminated meat products (beef, poultry, gravy) held at temperatures between 5°C and 60°C.
  • Soft-tissue infections typically associated with bacterial contamination of wounds or localized trauma.
• Diagnosis:
  • Reliably recognized in Gram-stained tissue specimens (large, rectangular, gram-positive rods).
  • Grows rapidly in culture with characteristic colony morphology and hemolytic pattern.
• Treatment, Prevention, and Control:
  • Rapid treatment is essential for serious infections.
  • Severe infections require surgical debridement and high-dose penicillin therapy.
  • Symptomatic treatment for food poisoning.
  • Proper wound care and judicious use of prophylactic antibiotics will prevent most infections.

Clostridium tetani

• Trigger Words: Spore former, environmental, neurotoxin, contaminated wounds, tetanus, vaccine.
• Biology and Virulence:
  • Extremely oxygen sensitive, making detection by culture difficult.
  • Primary virulence factor is tetanospasmin, a heat-labile neurotoxin that blocks release of neurotransmitters for inhibitory synapses (gamma-aminobutyric acid, glycine).
• Epidemiology:
  • Ubiquitous; spores are found in most soils and can colonize the gastrointestinal tract of humans and animals.
  • Exposure to spores is common, but disease is uncommon, except in developing countries with poor access to vaccine and medical care.
  • Risk is greatest for people with inadequate vaccine-induced immunity.
  • Disease does not induce immunity.
• Diseases:
  • Characterized by unrelenting muscle spasms and involvement of the autonomic nervous system.
• Diagnosis:
  • Based on clinical presentation, not laboratory tests.
  • Microscopy and culture are insensitive, and neither tetanus toxin nor antibodies are typically detected.
• Treatment, Prevention, and Control:
  • Treatment requires wound debridement, antibiotic therapy (penicillin, metronidazole), passive immunization with antitoxin globulin, and vaccination with tetanus toxoid.
  • Prevention through vaccination, consisting of three doses of tetanus toxoid followed by booster doses every 10 years.

Clostridium botulinum

• Trigger Words: Spore former, environmental, neurotoxin, foodborne and infant botulism, no vaccine.
• Biology and Virulence:
  • Multiple distinct botulinum toxins are produced, with human disease caused most commonly by types A and B; types E and F are also associated with human disease.
  • Botulinum toxin prevents release of the neurotransmitter acetylcholine, blocking neurotransmission at peripheral cholinergic synapses, leading to a flaccid paralysis.
• Epidemiology:
  • C. botulinum spores are found in soil worldwide.
  • Relatively few cases of botulism in the United States but prevalent in developing countries.
  • Infant botulism more common than other forms in the United States; associated with ingestion of contaminated soil or contaminated foods (particularly honey).
• Diseases:
  • Foodborne botulism is characterized by blurred vision, dry mouth, constipation, and abdominal pain, with progressive weakness of the peripheral muscles and flaccid paralysis.
  • Infant botulism begins with nonspecific symptoms but progresses to flaccid paralysis.
  • Other forms of botulism include wound botulism and inhalation botulism.
• Diagnosis:
  • Diagnosis of foodborne botulism is confirmed if toxin activity is demonstrated in the implicated food or in the patient’s serum, feces, or gastric fluid.
  • Infant botulism is confirmed if toxin is detected in the infant’s feces or serum, or the organism cultured from feces.
  • Wound botulism is confirmed if toxin is detected in the patient’s serum or wound, or the organism cultured from the wound.
• Treatment, Prevention, and Control:
  • Treatment involves the combination of administration of metronidazole or penicillin, trivalent botulinum antitoxin, and ventilatory support.
  • Spore germination in foods prevented by maintaining food at an acid pH, by high sugar content (e.g., fruit preserves), or by storing the foods at 4° C or colder.
  • Toxin is heat labile; therefore it can be destroyed by heating of food for 10 minutes at 60° C to 100° C.

General Characteristics of Clostridia

• Historically, the collection of all anaerobic gram-positive rods capable of forming endospores was in the genus Clostridium; however, clinically significant members of the genus can be misclassified by these criteria.
• Spores are only rarely demonstrated in some species (C. perfringens, C. ramosum).
• Some species are aerotolerant and can grow on agar media exposed to air (e.g., C. tertium, C. histolyticum).
• Some clostridia consistently stain gram-negative (e.g., C. ramosum, C. clostridioforme).
• Gene-sequencing techniques have led to reorganization of this heterogeneous collection of organisms into many new genera; however, most clinically significant species cluster in homology group I and remain in the genus Clostridium.
• Clostridia are ubiquitous in soil, water, and sewage and are part of the normal microbial population in the GI tracts of animals and humans.
• Most clostridia are harmless saprophytes, but some are well-recognized human pathogens with a clearly documented history of causing diseases such as diarrhea and colitis (C. difficile), food poisoning (C. perfringens), tetanus (C. tetani), botulism (C. botulinum), and myonecrosis (gas gangrene) (C. perfringens, C. septicum, C. sordellii).
• The remarkable ability of clostridia to cause diseases is attributed to:
  • Ability to survive adverse environmental conditions through spore formation.
  • Rapid growth in a nutritionally enriched, oxygen-deprived environment.
  • Production of numerous histolytic toxins, enterotoxins, and neurotoxins.

Clostridium difficile Pathogenesis

• C. difficile is a large ($0.5$ to $1.9 {x} 3.0$ to $17 µm$) anaerobic rod that freely forms spores in vivo and in culture.
• The organism grows rapidly in culture, although the vegetative cells (i.e., cells without a spore) die rapidly when exposed to oxygen.
• C. difficile produces a variety of volatile fatty acids that produce a characteristic “barnyard” smell in culture.
• Produces two toxins: an enterotoxin (toxin A) and a cytotoxin (toxin B).
• The enterotoxin is chemotactic for neutrophils, stimulating the infiltration of polymorphonuclear neutrophils into the ileum with release of cytokines.
• Toxin A also produces a cytopathic effect, resulting in disruption of the tight cell-to-cell junction, increased permeability of the intestinal wall, and subsequent diarrhea.
• The cytotoxin causes actin to depolymerize, with resultant destruction of the cellular cytoskeleton both in vivo and in vitro.
• Bacterial “surface layer proteins” are important for the binding of C. difficile to the intestinal epithelium, leading to localized production of toxins and subsequent tissue damage.

Clostridium perfringens Pathogenesis

• C. perfringens is a large ($0.6$ to $2.4 {x} 1.3$ to $19.0 µm$), rectangular, gram-positive rod, with spores rarely observed either in vivo or after in vitro cultivation, which is an important characteristic that differentiates this species from most other clostridia.
• Colonies of C. perfringens are also distinctive, with their rapid, spreading growth on laboratory media and β-hemolysis on blood-containing media.
• The production of one or more “major lethal” toxins by C. perfringens (alpha, beta, epsilon, and iota toxins) is used to subdivide isolates into five types (A through E).
• Alpha toxin, produced by all five types of C. perfringens, is a lecithinase (phospholipase C) that lyses erythrocytes, platelets, leukocytes, and endothelial cells.
• C. perfringens produces enterotoxin, primarily by type A strains, whose activity is enhanced by exposure to trypsin.

Clostridium tetani Pathogenesis

• C. tetani is a large ($0.5$ to $2 {x} 2$ to $18 µm$), motile, spore-forming rod.
• The organism produces round, terminal spores that give it the appearance of a drumstick.
• C. tetani produces two toxins, an oxygen-labile hemolysin (tetanolysin) and a plasmid-encoded, heat-labile neurotoxin (tetanospasmin).
• Tetanolysin is serologically related to streptolysin O and the hemolysins produced by C. perfringens and Listeria monocytogenes; however, the clinical significance of tetanolysin is unknown because it is inhibited by oxygen and serum cholesterol.
• Tetanospasmin (an A-B toxin) is synthesized as a single 150,000-Da peptide that is cleaved into a light (A chain) subunit and a heavy (B chain) subunit by an endogenous protease when the cell releases the neurotoxin.
• The light chain is a zinc endopeptidase that cleaves core proteins involved in the trafficking and release of neurotransmitters. Specifically, tetanospasmin inactivates proteins that regulate release of the inhibitory neurotransmitters glycine and gamma-aminobutyric acid (GABA).

Clostridium botulinum Pathogenesis

• Similar to tetanus toxin, C. botulinum toxin is a 150,000-Da progenitor protein (A-B toxin) consisting of a small subunit (light, or A chain) with zinc-endopeptidase activity and a large, nontoxic subunit (B, or heavy chain).
• In contrast with tetanospasmin, the botulinum neurotoxin remains at the neuromuscular junction.
• The botulinum endopeptidase then inactivates the proteins that regulate release of acetylcholine, blocking neurotransmission at peripheral cholinergic synapses.
• Because acetylcholine is required for excitation of muscle, the resulting clinical presentation of botulism is a flaccid paralysis.